Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
87 Cards in this Set
- Front
- Back
necessity of non pharm intervention (7)
|
1) elevated bp is a common and important risk factor for cv and renal diseases
2) 27% of americans have htn 3) 31% of americans have prehypertension 4) estimated that 1/3 of bp related deaths from chd occur in normal indivdiuals 5) once recommend treatment for prehypertensive patients if lifestyle modifications 6) in non ntn and pre HTN patients, dietary change that lower bp may: prevent htn from developing and lower the risk of htn related complications 7) small reducation in bp can have a big impact |
|
what areas do you put non pharm in soap
|
1) assessment
2) plan 3) patient education |
|
what are the nonpharm treatments for htn- 6
|
1) weight loss
2) adopt of DASH DIET 3) limit na intake 4) inc aerobic physical activity 5) limit etoh intake 6) encourage smoking cessation |
|
benefits of weight loss for bp
|
1) weight is directly associated with bp. weight loss lowers bp
2) reductions similar for HTN and on HTN subjects 3) modest weight loss +/- na restriction can: prevent htn 20% in overweight, pre HTN patients, lead to decreases in number of meds and or dose 4) does not prevent a rise in bp over time |
|
weight loss recommendation
a) overweight/ obese b) non overweight persons |
a) lose wt until attain bmi < 25 kg/ m2
b) maintain desirable bmi < 25 kg/ m2 |
|
what is emphasized in DASH diet- 7
|
- fruits
- veggies - low fat dairy products - whole grains - poultry - fish -nuts |
|
what is not emphasized in DASH diet - 5
|
- sat and total fat
- cho - red meat - sweets - sugar containing beverages |
|
adopting a dash diet
a) rich in what nutrients b) effect on bp c) how long does it take to see effect? d) effect on pop |
a) K, Mg, Ca, Fiber
b) reduceds sbp by 5.5 mmhg and dbp by 3 mmhg vs control diet c) 2 weeks d) blacks more than whites, htn more than non htn patients |
|
dash diet not recommended in patients with
|
- stage 3 and 4 ckd
- gfr < 60 ml/min/ 1.73 m2 - high in K, P, protein |
|
name other diets other than dash to reduce htn
|
1) vegetarian
2) omniheart trial |
|
vegetarian diet
a) effect on bp b) contributing factors- 5 |
a) associated w/ bp reduction. lowers bp than nonveg in industrialized countries
b) contributing factors - reduced wt - inc K -low to moderate etoh intake - high fiber - no meat |
|
omni heart trial consists of what kind of diets- 3
|
diets rich in:
- rich in carbs- 58% of total calories - rich in protein- 50% frm plant sources - rich in unsat fats- mostly monounsat |
|
omni heart trial
a) overall assess of 3 diets b) effect on bp c) effect of carb substitution |
a) overall diet
- reduce in sat fat and cho - rich in fruit, vegs, fiber, P, and other minerals b) each diet reduced sbp b/t 5-10 mmHg c) substitution of carbs (10% of total calories) with either protein or unsat fats led to further bp red |
|
effect of dietary salt on bp?
|
- inc in dietary salt, bp inc
|
|
effect of dietary na restriction on bp for gender, ethnicity and htn status
|
- significant lowers bp across genders, ethnicity and htn
|
|
effect of reduction of na from 3.3 g to 1.5 g results in what effect on s and d bp
|
S: red sbp by 2 mmHg (non-HTN) and 5 in mmHg (htn)
D: red dbp by 1 mmHg (non-HTN) and 2.7 mmHg (HTN) |
|
reduced na intake + weight loss can prevent HTN by ?
|
20%
|
|
t/f not everyone responds to na restriction the same
|
true
|
|
dietary na restriction has greater effects in patients who have?
|
less responsive RAAS
|
|
dietary na restriction is more pronounced effect in bp for what pop- 5
|
- blacks
-htn patients - ckd patients - diabetes |
|
if you put dietary na restriction in soap note, what is the reco you would make
|
-reduce 2.4 g/d or Na or 6 g/d of NaCl
|
|
if you put dietary na restriction in soap note, what patient counseling tip would you put?
|
- choose foods low in salt
- limit amt of salt added to food - minimize processes foods |
|
effect on k on bp
|
- increase K assocaited w/ red bp in htn and non HTN subjects
|
|
what is the effect of inc K by 2g/d on s and d bp
|
- dec sbp by 4.4 mmHg (HTN) and 1.8 mmHg (non-HTN)
- dec dbp by 2.5 mmHg (HTN) and 1 mmHg (non-HTN) |
|
blacks or whites benefit more from inc K intake
|
blacks
|
|
the effect of K on bp are dependent on Na intake - t/f , if so, how?
|
-true
- effects on bp greater in high Na intake subjects - effects on bp lower in low na intake subjects |
|
average intake of K for women and men
|
adult women: 2.1-2.3 g/d
adult male: 2.9- 3.2 g/d |
|
reco for increased K intake to lower bp ?
|
- > 4.7 g/d in most patients
- < 4.7 g/d in pat with impaired K excretion |
|
what drugs (4) and disease (5) impair K excretion
|
drugs
- acei -arb - nsaid - K sparring diuretics diseases - dm -cri - esrd - severe HF - adrenal insuff |
|
reco for increasing physical activity
|
- regular aerobic physical activity: brisk walking, bike riding, swimming
- 30 mins /day on most days of the week. AHA min reco is 3 days/ wk |
|
alcohol relationship w/ bp
|
alcohol has a dose dependent relationship w/ inc bp
|
|
how many drinks does it take to reduce bp and chd risk
|
less than or equal to 2 r
|
|
reco for moderate alcohol intake-3
|
- less than or equal to 2 drinks in men and less than or equal to 1 drink in women
- do not recommend patients to start drinking - only reco to reduce amt |
|
how is a drink defined
|
-12 oz of regular beer
-5 oz of wine (12% etoh) -1.5 oz of 80 proof (40% etoh) distilled spirits |
|
cigarette smoking is dependent/independent risk factor for CHD?
|
independent risk factor for CHD
|
|
htn patients who smoke need to be counseled on ? (3)
|
- risk and benefits of smoking cessation
- smoking cessation programs - smoking cessation aids |
|
fish oil supplementation and effect on htn
a) dose b) effect on bp c) adr |
a) high dose of omega 3 fa > 3g/d
b) can dec sbp by 4 and dbp by 2.5 in HTN patients c) adr: bleeding, belching, and fish taste, not routinely reco due to high dose |
|
other dietary factors that do not have enough info to have effect on bp- 8
|
- fiber
- ca - mg - carb consumption - protein intake - fat intake - cho - vit c |
|
how many different antihypertensive drug classes are there
|
10
|
|
primary anti HTN agents-5
|
- diuretics
- bb - acei - angiotensin II receptor blockers - ccb |
|
alternative anti-HTN agents-5
|
- alpha 1 blockers
- central alpha 2 agonists - adrenergic inhibitors - vasodilators - direct renin inhibitors |
|
what drug class is the first line agent for most patients w/ HTN
|
thiazide type diuretics
-based on the ALLHAT study |
|
explain the synergistic effect of diuretics
|
- diuretics are very good agents to use in conjunction with other therapies to achieve bp goals
- pharmacodynamic synergy - anti- htn may have a compenstaory inc in na and water retention, ie: acei/arb body will keep na, |
|
categories of diuretic agents
|
- thiazide
- loop - K sparing diuretics - aldosterone antag |
|
name a thiazide diuretics
|
hydrochlorothiazide (Hydrodiuril)
|
|
gen: hydrochlorothiazide
brand? class: |
gen: hydrochlorothiazide
brand: hydroDiuril class: thiazide diuretic |
|
dosing of hydrochlorothiazide( Hydrodiuril)
|
12.5- 50 mg po daily
|
|
name a loop diuretic
|
furosemide (lasix)
|
|
gen: furosemide
brand:? class:? |
gen: furosemide
brand: lasix class: loop d |
|
dosing of furosemide (lasix)
|
20-40 mg po bid
|
|
name aldosterone antag (2)
|
eplerenone (inspra)
spironolactone (aldactone) |
|
gen: eplerenone
brand:? class:? |
gen: eplerenone
brand: inspra class: aldosterone antag, diuretic |
|
gen: spironolactone
brand:? class:? |
gen: spironolactone
brand: aldactone class: aldosterone antag, diuretic |
|
dosing of spironolactone
|
25-50 mg po daily or bid
|
|
dosing of eplerenone
|
50 mg po daily or bid
|
|
thiazide moa- 4
|
1) inhibit na and cl transport in the cortical thick ascending limb and the early distal tubule
2) less na is reabsorbed by this nephron site than by the thick ascending (loop). milder diuretic axn than loop diuretics. 3) initially produce natriuresis that dec plasma vl, but dec w/ chronic use 4) long term effects are throught to be due to direct relaxation of vascular smooth muscle |
|
what is more potent diuretic: thiazide or loop
|
loop
|
|
moa of loop d
|
- block the na/k/chloride co transporter in the thick ascending limb of henle's loop
- most potent diuretics avail |
|
moa of K sparing diuretics
|
- inhibit na channel in the late distal tubule and collecting duct
- causes a lack of exchange of K |
|
moa of aldosterone antag
|
- competitively block aldosterone at receptor site
-not a true diuretic |
|
what are the ci for diuretics
|
1) sulfa allergy
- can't use thiazide or loop - use epicrynic acid 2) crcl <30 ml/min - thiazides can't be used 3) Scr - monitor when using aldosterone antag - Eplerenone (>2 mg/dL in men and >1.8 mg/dL in women, t2dm with proteinuria) -Spironolactone (>2.5 mg/dl in men and >2.0 in women) 4) hyperkalemia (K>5.0 meq/l) - dnt use K sparing diuretics and aldosterone antag |
|
when using aldosterone antag what is the ci
|
- watch for scr
- Eplerenone (>2 mg/dL in men and >1.8 mg/dL in women, t2dm with proteinuria) -Spironolactone (>2.5 mg/dl in men and >2.0 in women) |
|
if clcr <30 what is the diuretic you can use
|
metolazone is the only thiazide effective if crcl <30
|
|
thiazide precautions- 3
|
-hypokalemia
- gout (inc uric acid) - hypercalemia |
|
loop precautions
|
- hypokalemia
- hypocalcemia |
|
benefits of thiazide- 4
|
1) most effect to dec bp
2) reduce sbp by 12-18 mmHg 3) only use in patients w/ crcl >30 ml/min 4) excellent to educe bp in blacks that are resistant to bb and acei |
|
benefits of loop d-1
|
1) CrCl <30 ml/min. otherwise use thiazide.
|
|
benefits of K sparing diuretics - 2
|
1) weak antiHTN agents when used alone
2) useful for patients that have risk of hypoK w/ thiazide or loop (serum K <4) |
|
benefits of aldosterone antag- 2
|
1) decent diuretic properties but main effect is an aldosterone receptor blocker
2) proven to reduce M&M - stage III-IV hf - post mi w/ lvd |
|
adr in thiazides-3
|
hypo: K, Mg
hyper: Ca, uricemia, glycemia, lipidemia sexual dysfunction |
|
adr in loop- 3
|
hypo: K, Mg, Ca
hyper: uricemia, glycemia, lipidemia ototoxicity |
|
K sparing diuretics adr
|
hyperkalemia
|
|
aldosterone antag adr- 3
|
1) hyperkalemia
2) gynecomastia (spironolactone) 3) hypertriglyceridemia (eplerenone) |
|
patient counseling for diuretics- 3
|
1) dose
- daily dosing: dose in morning - bid dosing: dose in am and afternoon 2) signs and symptoms of hypokalemia - muscle fatigue or cramps 3) monitor for signs of dizziness |
|
6 acei agents
|
1) benazepril (lotensin)
2) captopril (capoten) 3) enalapril (vasotec) 4) fosinopril (monopril) 5) lisinopril (prinvil, zestril) 6) ramipril (altace) |
|
generic: benazepril
brand: ? class: ? |
generic: benazepril
brand: lotensin class: acei |
|
generic: captopril
brand: ? class: ? |
generic: captopril
brand: capoten class: acei |
|
generic: enalapril
brand: ? class: ? |
generic: enalapril
brand: vasotec class: acei |
|
generic: fosinopril
brand: ? class: ? |
generic: fosinopril
brand: monopril class: acei |
|
generic: lisinopril
brand: ? class: ? |
generic: lisinopril
brand: prinvil, zestril class: acei |
|
generic: ramapril
brand: ? class: ? |
generic: ramapril
brand: altace class: acei |
|
dosing of benazepril (lotensin)
max dosage? |
10-40 mg qd-bid
max: 40 |
|
dosing of captopril (capoten)
max dosage? |
6.25-50 mg bid- tid
max: 450 |
|
dosing of enalapril (vasotec)
max dosage? |
2.5-40 mg qd-bid
max: 40 |
|
dosing of fosinopril (monopril)
max dosage? |
10-40 mg daily
max: 40 |
|
dosing of lisinopril (prinvil, zestril)
max dosage? |
10-40 mg daily
max: 40 |
|
dosing of ramipril (altace)
max dosage? |
2.5-10 mg qd-bid
max: 20 |